First Tracks Biotherapeutics TRAX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$3.83M (11 inflow days, 9 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 31.5% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 10.89% to 14.08% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Adage Capital Management, L.P. | Hedge Fund | 2026/Q3 | +1,348,179 | 4.9% |
| Invesco Ltd. | Mutual Fund | 2026/Q3 | +715,914 | 1.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +594,932 | 6.1% |
| EcoR1 Capital, LLC | Hedge Fund | 2026/Q3 | +3,174,519 | 7.6% |
| TCG Crossover Management, LLC | VC/PE Fund | 2026/Q3 | +2,895,304 | 6.9% |
| Sirenia Capital Management LP | Mutual Fund | 2026/Q3 | +2,495,777 | 5.9% |
| FMR | Mutual Fund | 2026/Q3 | +2,054,048 | 4.9% |
| Affinity Asset Advisors, LLC | Hedge Fund | 2026/Q3 | +2,032,012 | 4.8% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,963,541 | 5.5% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +1,643,129 | 3.9% |
| Trails Edge Capital Partners, LP | Hedge Fund | 2026/Q3 | +1,514,000 | 3.6% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,512,896 | 3.6% |
| Janus Henderson Group plc | Mutual Fund | 2026/Q3 | +1,091,464 | 2.6% |
| Vestal Point Capital, LP | Hedge Fund | 2026/Q3 | +1,013,000 | 2.4% |
| Woodline Partners LP | Hedge Fund | 2026/Q3 | +917,176 | 2.2% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 31 Oct 2026 | Ajim Tamboli | Chief Financial Officer | Other Derivative Acquisition | +42,500 | – | 42,500 |
| 31 Oct 2026 | Paul Lizzul | Chief Medical Officer | Other Derivative Acquisition | +42,500 | – | 42,500 |
| 31 Oct 2026 | Daniel Faga | Chief Executive Officer | Other Derivative Acquisition | +136,000 | – | 136,000 |
| 31 Oct 2026 | Benjamin Stone | Chief Business Officer | Other Derivative Acquisition | +42,500 | – | 42,500 |
| 14 Sep 2026 | John Orwin | Independent Chairperson | Derivative Exercise and Retained | +1,300 | – | 17,995 |
| 1 Sep 2026 | J. Ware | Independent Director | Derivative Exercise and Sale | -39,265 | $44.78 | 15,660 |
| 14 Aug 2026 | Paul Lizzul | Chief Medical Officer | Other Derivative Acquisition | +60,492 | – | 137,651 |
| 14 Aug 2026 | Daniel Faga | Chief Executive Officer | Other Derivative Acquisition | +193,575 | – | 440,485 |
| 14 Aug 2026 | Benjamin Stone | Chief Business Officer | Other Derivative Acquisition | +60,492 | – | 137,651 |
| 1 Aug 2026 | Paul Lizzul | Chief Medical Officer | Other Derivative Acquisition | +60,492 | – | 77,159 |
| 1 Aug 2026 | Daniel Faga | Chief Executive Officer | Other Derivative Acquisition | +193,576 | – | 387,156 |
| 1 Aug 2026 | Benjamin Stone | Chief Business Officer | Other Derivative Acquisition | +60,492 | – | 77,159 |
| 14 Jun 2026 | John Orwin | Independent Chairperson | Derivative Exercise and Retained | +6,030 | – | 16,695 |
| 14 Jun 2026 | John Schmid | Independent Director | Derivative Exercise and Retained | +6,030 | – | 37,652 |
| 14 Jun 2026 | Dennis Fenton | Independent Director | Derivative Exercise and Retained | +6,030 | – | 10,995 |
| 14 Jun 2026 | Magda Marquet | Independent Director | Derivative Exercise and Retained | +6,030 | – | 15,960 |
| 14 Jun 2026 | J. Ware | Independent Director | Derivative Exercise and Retained | +6,030 | – | 15,660 |
| 14 Jun 2026 | Rita Jain | Independent Director | Derivative Exercise and Retained | +7,330 | – | 19,194 |
| 11 May 2026 | John Orwin | Independent Chairperson | Other Derivative Acquisition | +2,500 | – | 2,500 |
| 11 May 2026 | John Orwin | Independent Chairperson | Other Derivative Acquisition | +7,000 | $17.81 | 7,000 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 5,056,413 | 14.1% | 6.5 |
| 15 Oct 2026 | 6,958,100 | 19.5% | 4.8 |
| 30 Sep 2026 | 5,190,809 | 14.5% | 6.2 |
| 15 Sep 2026 | 4,500,079 | 12.6% | 7.5 |
| 31 Aug 2026 | 4,030,463 | 11.3% | 7.2 |
| 14 Aug 2026 | 3,892,563 | 10.9% | 6.8 |
No comments yet — be the first to weigh in on TRAX.
Sign in to join the discussion.